Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC
ROCKVILLE, Md. and SUZHOU, China, Oct. 7, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering,…
